Abstract
In recent years, the cost of intensive care treatment has become increasingly important to managers and medical professionals. In fact, every treatment could be discussed in the context of a cost-benefit analysis. At present, most hospitals have a committee that studies the need for all newly introduced medications and facilities. A cost analysis is usually performed. If SDD is introduced in a hospital, the medical staff and managers may be confronted with the question of its cost and benefits. The purpose of this chapter is to review the current literature relating to the cost of SDD.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jegers M, Edbrooke DL, Hibbert CL et al (2002) Definitions and methods of cost assessment: an intensivist’s guide. Intensive Care Med 28:680–685
De Jonge E, Schulz MJ, Spanjaart L et al (2003) Effects of Selective Decontamination of the Digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362:1011–1016
Abele-Horn M, Dauber A, Bauernfeind A et al (1997) Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD). Intensive Care Med 23:187–195
Quinio B, Albanese J, Bues-Charbit M et al (1996) Selective decontamination if the digestive tract in multiple trauma. Chest 109:765–772
Van Nieuwenhoven CA, Buskens E, Bergmans DC, Van Tiel F et al (2004) Oral decontamination is cost-saving in the prevention of ventilator-associated Pneumonia in intensive care units. Crit Care Med 32:126–130
Korinek AM, Laisne MJ, Nicholas MH et al (1993) Selective decontamination of the digestive tract in neurosurgical intensive care unit patients. A double-blind, randomised, placebocontrolled study. Crit Care Med 21:1466–1473
Rocha LA, Martin MJ, Pita S, (1992) Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract: a randomised, double-blind, placebo-controlled study. Intensive Care Med 18:398–404
Langlois-Karaga A, Bues-Charbit M, Davignon A et al (1995) Selective digestive decontamination in multiple trauma patients: cost and efficacy. Pharm World Sci 17:12–16
Wiener J, Itokazu G, Nathan C (1995) A randomized, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit. Clin Infect Dis 20:861–867
Gastinne H, Wolff M, Delatour F et al (1992) A controlled trial in intensive care units of selective decontamination of the digestive tract with non-absorbable antibiotics. N. Engl J Med 326:594–599
Van Enckevort PJ, Zwaveling JH, Bottema JT et al (2001) Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics 19:523–530
Zwaveling JH, Maring JK, Klompmaker IJ et al (2002) Selective decontamination of the digestive tract to prevent postoperative infection: A randomized placebo-controlled trial in liver transplant patients. Crit Care Med 30:1204–1209
Hellinger WC, Yao JD, Alvarez S et al (2002) A randomised, prospective, double-blind evaluation of selective bowel decontamination in liver transplantation. Transplantation 73:1904–1909
Stoutenbeek CP, van Saene HKF, Zandstra DF (1996) Prevention of multiple organ system failure by selective decontamination of the digestive tract in multiple trauma patients. In: Faist EBAE, Baue AE, Schildberg FW (eds) The immune consequences of trauma, shock and sepsis-mechanisms and therapeutic approaches. Lengerich: Pabst Science Publishers, pp 1055–1066
Schardey HM, Joosten U, Finke U et al (1997) Kostensenkung durch Dekontamination zur Prävention der Nahtinsuffizienz nach Gastrectomie. Chirurg 68:416–424
van der Voort PHJ, van Roon EN, Kampinga GA et al (2004) A before-after study of multiresistance and cost of selective decontamination of the digestive tract. Infection 32:271–277
Verwaest C, Verhaegen J, Ferdinande P et al (1997) Randomized controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 25:63–71
Lingnau W, Berger J, Javorsky F et al (1997) Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma 42:687–693
Sanchez Garcia M, Cambronero Galache A, Lopez Diaz J et al (1998) Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. Am J Respir Crit Care Med 158:908–916
Rolando N, Gimson A, Wade J et al (1993) Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 17:196–201
Making health care safer: a critical analysis of patient safety practices 2001. www.ahrq.gov/clinic/ptsafety
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
van der Voort, P.H.J. (2008). The Costs of SDD. In: van der Voort, P.H.J., van Saene, H.K.F. (eds) Selective Digestive Tract Decontamination in Intensive Care Medicine: a Practical Guide to Controlling Infection. Springer, Milano. https://doi.org/10.1007/978-88-470-0653-9_10
Download citation
DOI: https://doi.org/10.1007/978-88-470-0653-9_10
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0652-2
Online ISBN: 978-88-470-0653-9
eBook Packages: MedicineMedicine (R0)